Mitochondria-independent morphological and biochemical apoptotic alterations promoted by the anti-tumor agent bleomycin in Saccharomyces cerevisiae

Biochem Cell Biol. 2007 Feb;85(1):49-55. doi: 10.1139/o06-147.

Abstract

Bleomycin is a highly potent cytotoxic and genotoxic agent used in the chemotherapy of various types of tumors. It is a radiomimetic anticancer drug that produces single- and double-stranded DNA breaks in a catalytic way. Using Saccharomyces cerevisiae as a model system, we show that when a high amount of bleomycin molecules is internalized (100 micromol/L), morphological changes identical to those usually associated with apoptosis, i.e., a sub-G1 region peak, chromatin condensation, and very rapid DNA fragmentation into oligonucleosomal-sized fragments, are observed. The known bleomycin inhibitors cobalt and EDTA were able to prevent bleomycin nucleasic activity and thus apoptotic cell death. However, both oligomycin, a potent inhibitor of the mitochondrial F0F1-ATPase, and antimycin, a drug affecting mitochondria respiration, were unable to prevent the bleomycin-induced apoptotic-like cell death. These results suggest that high bleomycin concentrations induce an apoptosis-like mitochondria-independent cell death in yeast.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology*
  • Antimycin A / analogs & derivatives
  • Antimycin A / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Bleomycin / pharmacology*
  • Chromatin Assembly and Disassembly / drug effects
  • Chromatin Assembly and Disassembly / physiology
  • DNA Fragmentation
  • Edetic Acid / pharmacology
  • Mitochondria / drug effects*
  • Oligomycins / pharmacology
  • Saccharomyces cerevisiae / drug effects*

Substances

  • Antibiotics, Antineoplastic
  • Oligomycins
  • Bleomycin
  • antimycin
  • Antimycin A
  • Edetic Acid